144 related articles for article (PubMed ID: 18559353)
21. The pharmacokinetics of oral dihydroartemisinin and artesunate in healthy Thai volunteers.
Na-Bangchang K; Krudsood S; Silachamroon U; Molunto P; Tasanor O; Chalermrut K; Tangpukdee N; Matangkasombut O; Kano S; Looareesuwan S
Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):575-82. PubMed ID: 15689069
[TBL] [Abstract][Full Text] [Related]
22. Chemical stability of artesunate injection and proposal for its administration by intravenous infusion.
Batty KT; Ilett KF; Davis T; Davis ME
J Pharm Pharmacol; 1996 Jan; 48(1):22-6. PubMed ID: 8722489
[TBL] [Abstract][Full Text] [Related]
23. Population pharmacokinetics of artemether and dihydroartemisinin following single intramuscular dosing of artemether in African children with severe falciparum malaria.
Mithwani S; Aarons L; Kokwaro GO; Majid O; Muchohi S; Edwards G; Mohamed S; Marsh K; Watkins W
Br J Clin Pharmacol; 2004 Feb; 57(2):146-52. PubMed ID: 14748813
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic profiles of artesunate after single intravenous doses at 0.5, 1, 2, 4, and 8 mg/kg in healthy volunteers: a phase I study.
Li Q; Cantilena LR; Leary KJ; Saviolakis GA; Miller RS; Melendez V; Weina PJ
Am J Trop Med Hyg; 2009 Oct; 81(4):615-21. PubMed ID: 19815876
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the pharmacokinetic profile of artesunate, artemether and their metabolites in sheep naturally infected with Fasciola hepatica.
Duthaler U; Huwyler J; Rinaldi L; Cringoli G; Keiser J
Vet Parasitol; 2012 May; 186(3-4):270-80. PubMed ID: 22206644
[TBL] [Abstract][Full Text] [Related]
26. Population pharmacokinetics of intramuscular artesunate in African children with severe malaria: implications for a practical dosing regimen.
Hendriksen IC; Mtove G; Kent A; Gesase S; Reyburn H; Lemnge MM; Lindegardh N; Day NP; von Seidlein L; White NJ; Dondorp AM; Tarning J
Clin Pharmacol Ther; 2013 May; 93(5):443-50. PubMed ID: 23511715
[TBL] [Abstract][Full Text] [Related]
27. Artesunate/dihydroartemisinin pharmacokinetics in acute falciparum malaria in pregnancy: absorption, bioavailability, disposition and disease effects.
McGready R; Phyo AP; Rijken MJ; Tarning J; Lindegardh N; Hanpithakpon W; Than HH; Hlaing N; Zin NT; Singhasivanon P; White NJ; Nosten F
Br J Clin Pharmacol; 2012 Mar; 73(3):467-77. PubMed ID: 21950338
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of dihydroartemisinin in Artekin tablets for single and repeated dosing in Chinese healthy volunteers.
Hong X; Liu CH; Huang XT; Huang TL; Ye SM; Ou WP; Wang NS; Mi SQ
Biopharm Drug Dispos; 2008 May; 29(4):237-44. PubMed ID: 18350560
[TBL] [Abstract][Full Text] [Related]
29. Validation of high performance liquid chromatography-electrochemical detection methods with simultaneous extraction procedure for the determination of artesunate, dihydroartemisinin, amodiaquine and desethylamodiaquine in human plasma for application in clinical pharmacological studies of artesunate-amodiaquine drug combination.
Lai CS; Nair NK; Muniandy A; Mansor SM; Olliaro PL; Navaratnam V
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Feb; 877(5-6):558-62. PubMed ID: 19147417
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of artemisinin and artesunate after oral administration in healthy volunteers.
Benakis A; Paris M; Loutan L; Plessas CT; Plessas ST
Am J Trop Med Hyg; 1997 Jan; 56(1):17-23. PubMed ID: 9063354
[TBL] [Abstract][Full Text] [Related]
31. Antimalarial bioavailability and disposition of artesunate in acute falciparum malaria.
Newton P; Suputtamongkol Y; Teja-Isavadharm P; Pukrittayakamee S; Navaratnam V; Bates I; White N
Antimicrob Agents Chemother; 2000 Apr; 44(4):972-7. PubMed ID: 10722499
[TBL] [Abstract][Full Text] [Related]
32. Absence of time-dependent artesunate pharmacokinetics in healthy subjects during 5-day oral administration.
Diem Thuy LT; Ngoc Hung L; Danh PT; Na-Bangchang K
Eur J Clin Pharmacol; 2008 Oct; 64(10):993-8. PubMed ID: 18600318
[TBL] [Abstract][Full Text] [Related]
33. Population pharmacokinetics of artesunate and dihydroartemisinin during long-term oral administration of artesunate to patients with metastatic breast cancer.
Ericsson T; Blank A; von Hagens C; Ashton M; Äbelö A
Eur J Clin Pharmacol; 2014 Dec; 70(12):1453-63. PubMed ID: 25248945
[TBL] [Abstract][Full Text] [Related]
34. Toxicokinetics and hydrolysis of artelinate and artesunate in malaria-infected rats.
Li Q; Xie LH; Si Y; Wong E; Upadhyay R; Yanez D; Weina PJ
Int J Toxicol; 2005; 24(4):241-50. PubMed ID: 16126618
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and pharmacodynamics of intravenous artesunate during severe malaria treatment in Ugandan adults.
Byakika-Kibwika P; Lamorde M; Mayito J; Nabukeera L; Mayanja-Kizza H; Katabira E; Hanpithakpong W; Obua C; Pakker N; Lindegardh N; Tarning J; de Vries PJ; Merry C
Malar J; 2012 Apr; 11():132. PubMed ID: 22540954
[TBL] [Abstract][Full Text] [Related]
36. Opposite malaria and pregnancy effect on oral bioavailability of artesunate - a population pharmacokinetic evaluation.
Kloprogge F; McGready R; Phyo AP; Rijken MJ; Hanpithakpon W; Than HH; Hlaing N; Zin NT; Day NP; White NJ; Nosten F; Tarning J
Br J Clin Pharmacol; 2015 Oct; 80(4):642-53. PubMed ID: 25877779
[TBL] [Abstract][Full Text] [Related]
37. Effects of body size and gender on the population pharmacokinetics of artesunate and its active metabolite dihydroartemisinin in pediatric malaria patients.
Morris CA; Tan B; Duparc S; Borghini-Fuhrer I; Jung D; Shin CS; Fleckenstein L
Antimicrob Agents Chemother; 2013 Dec; 57(12):5889-900. PubMed ID: 24041884
[TBL] [Abstract][Full Text] [Related]
38. A simplified liquid chromatography-mass spectrometry assay for artesunate and dihydroartemisinin, its metabolite, in human plasma.
Teja-Isavadharm P; Siriyanonda D; Siripokasupkul R; Apinan R; Chanarat N; Lim A; Wannaying S; Saunders D; Fukuda MM; Miller RS; Weina PJ; Meléndez V
Molecules; 2010 Dec; 15(12):8747-68. PubMed ID: 21124272
[TBL] [Abstract][Full Text] [Related]
39. Oral bioavailability of dihydroartemisinin in Vietnamese volunteers and in patients with falciparum malaria.
Binh TQ; Ilett KF; Batty KT; Davis TM; Hung NC; Powell SM; Thu LT; Thien HV; Phuöng HL; Phuong VD
Br J Clin Pharmacol; 2001 Jun; 51(6):541-6. PubMed ID: 11422013
[TBL] [Abstract][Full Text] [Related]
40. Bioavailability and preliminary clinical efficacy of intrarectal artesunate in Ghanaian children with moderate malaria.
Krishna S; Planche T; Agbenyega T; Woodrow C; Agranoff D; Bedu-Addo G; Owusu-Ofori AK; Appiah JA; Ramanathan S; Mansor SM; Navaratnam V
Antimicrob Agents Chemother; 2001 Feb; 45(2):509-16. PubMed ID: 11158748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
